Skip to main content
  1. Home
  2. Emerging Tech
  3. Health & Fitness
  4. News

CRISPR’s latest achievement? Taking the gluten out of wheat

Add as a preferred source on Google

Avoiding gluten may be about to get a whole lot easier — and it’s all thanks to CRISPR gene editing. That’s because a team of researchers at the Institute for Sustainable Agriculture in Cordoba, Spain have used the technology to eliminate the majority of the gliadins (the gluten proteins which cause most of the gluten intolerance issues for people with celiac disease) in wheat.

“Gluten proteins, and specifically gliadins, are major [factors] responsible of triggering celiac disease in genetically predisposed individuals,” Dr. Francisco Barro Losada, the geneticist whose team carried out the research, told Digital Trends. “There are many gliadin genes in the grain of wheat, which makes it impossible to obtain gliadin-free wheat lines using classic breeding methods. Gene editing by CRISPR/Cas allow the introduction of mutations in specific genes, and shutting down [of] those genes. In this work, we were able to mutate 35 out of 45 gliadin genes in bread wheat, and reduce wheat toxicity up to 85 percent. This is an unprecedented application of CRISPR/Cas technology. The low-gluten, transgene-free wheat lines described in the work constitute an unprecedented advance, and the resultant lines provide excellent source material for plant breeding programs to introgress the low-gluten trait into elite wheat varieties.”

Recommended Videos

Barro Losada points out that at present the resulting wheat isn’t (yet) suitable for celiac disease patients — since it still contains some gluten, even though this is at a lower quantity. However, the wheat could still be used to prepare low gluten foods for those who wants to reduce their intake of gluten. Because there is a sizable group of people able to tolerate only low amounts of gluten, this could be a major benefit to them.

“We are working now with the gliadin genes still present in these lines,” Barro Losada continued. Specifically, the team hopes to be able to disable the remaining 10 genes to make sure that no gliadin proteins are produced. Should all go to plan, and provided that this is deemed to be safe through the proper channels, hopefully it won’t be long before a whole new range of gluten-free products appear on grocery store shelves everywhere.

A paper describing the work was recently published in Plant Biotechnology Journal.

Luke Dormehl
I'm a UK-based tech writer covering Cool Tech at Digital Trends. I've also written for Fast Company, Wired, the Guardian…
Intelligent UI turns ChatGPT answers into interactive tools while GPT-6 rolls out to a broader audience 
Plain text answers just got a very interactive rival.
Intelligent UI in ChatGPT.

Would you rather read instructions for splitting a dinner bill or tap a bill splitter and let it do the math? I'd pick the latter. 

OpenAI's SOl-6 rollout, starting October 7, 2026, adds Intelligent UI. Basically, it lets the chatbot assemble interactive answers instead of replying in plain text.

Read more
Checking body medication levels may now be as easy as sucking on a peach-flavoured lollipop
Forget the clinic swab; this lollipop wants a lick
Lollylab

Checking your body’s medication levels is usually no one’s idea of fun. Now researchers are trying to change that with Lollylab, a candy-coated, lollipop-like device that can collect saliva and measure levels of acetaminophen in under two minutes.

The prototype created by researchers whose work was published in ACS Sensors transforms a familiar object into a miniature testing device. In a pilot study, six adults ingested the peach-flavored Lollylab before and one hour after a standard 650-milligram dose of acetaminophen. The device repeatedly detected the pain reliever in their saliva, and participants reported it was more comfortable and easier to use than traditional saliva swabs.

Read more
A US state just approved an AI doctor. For now, it’ll only prescribe acne cures.
Aside from acne, Nolla's AI can also handle redness, fine lines and wrinkles, hyperpigmentation and dark spots, and under-eye bags.
Nolla Derm AI doctor app.

The first AI doctor is here. Despite all the skepticism and risks associated with AI models going haywire, the state of Utah just approved Nolla Health, a company that is providing an AI healthcare expert capable of writing prescriptions without any human in the chain. For now, it will only write acne prescriptions for Utah residents over 18 years of age, willing to pay a token monthly subscription fee that's lighter than your Spotify bill.

The big push here is that the Nolla Derm app will reduce the costs of medical consultation, save users the hassle of clinic visits, and take out the problem of waitlisting from the entire healthcare equation. “Unlike telehealth platforms that use AI only to collect information before handing patients off to clinicians, Nolla's AI system is designed to independently issue initial prescriptions within tightly defined, physician-approved treatment protocols,” writes the company. 

Read more